CRISPR-Cas9 in Clinical Trials: Recent Breakthroughs & Limitations
A comprehensive review of ongoing Phase III trials, off-target effect mitigation strategies, and regulatory pathways for therapeutic gene editing in hereditary blood disorders.
Explore the intersection of hereditary biology and clinical medicine. From CRISPR breakthroughs to pharmacogenomics, discover peer-reviewed articles, case studies, and the latest genomic research shaping modern healthcare.
A comprehensive review of ongoing Phase III trials, off-target effect mitigation strategies, and regulatory pathways for therapeutic gene editing in hereditary blood disorders.
How genetic variations in cytochrome P450 enzymes impact antidepressant and antipsychotic metabolism, with clinical dosing algorithms and FDA table references.
Updated consensus recommendations for colorectal and endometrial cancer screening in MLH1, MSH2, MSH6, and PMS2 mutation carriers across diverse populations.
Exploring horvath and hanham clocks, their clinical utility in oncology, cardiovascular risk stratification, and anti-aging intervention trials.
Meta-analysis of diagnostic yields across pediatric and adult cohorts, reimbursement frameworks, and the evolving role of tertiary genetics centers.
Comparative analysis of WHO guidelines, national legislation, and ethical frameworks surrounding heritable human genome modification.